Victory Capital Management Inc. Raises Stock Holdings in Cigna Group $CI

Victory Capital Management Inc. increased its stake in shares of Cigna Group (NYSE:CI) by 1.2% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 955,735 shares of the health services provider’s stock after purchasing an additional 10,912 shares during the period. Victory Capital Management Inc.’s holdings in Cigna Group were worth $275,491,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of CI. Mirae Asset Global Investments Co. Ltd. lifted its position in Cigna Group by 11.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock worth $13,039,000 after buying an additional 4,738 shares during the last quarter. Maj Invest Holding A S increased its position in Cigna Group by 2.4% during the third quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock valued at $121,854,000 after acquiring an additional 10,042 shares during the last quarter. Providence Capital Advisors LLC raised its stake in shares of Cigna Group by 1,016.8% in the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock valued at $2,453,000 after acquiring an additional 7,748 shares during the period. National Pension Service lifted its holdings in shares of Cigna Group by 3.2% in the 3rd quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after acquiring an additional 21,203 shares during the last quarter. Finally, SCS Capital Management LLC boosted its stake in shares of Cigna Group by 39.1% during the 2nd quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock worth $10,127,000 after purchasing an additional 8,609 shares during the period. 86.99% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Sanford C. Bernstein reissued a “market perform” rating and issued a $307.00 price objective on shares of Cigna Group in a research report on Tuesday, January 6th. Leerink Partners upped their target price on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research note on Friday, February 6th. Jefferies Financial Group increased their price target on Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a report on Monday, February 9th. UBS Group restated a “buy” rating and set a $375.00 price objective on shares of Cigna Group in a report on Monday, February 9th. Finally, Robert W. Baird reduced their target price on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and a consensus price target of $330.42.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reaffirmed its 2026 financial outlook alongside the CEO succession, and Brian Evanko was elected to the board — the company’s guidance reaffirmation reduces near-term earnings uncertainty. PR Newswire release
• Positive Sentiment: Cigna raised its quarterly dividend (to $1.56 per share), which supports yield-seeking investors and signals confidence in cash flow. MarketBeat Cigna page
• Positive Sentiment: Piper Sandler maintained an Overweight rating and a $370 price target, reflecting continued analyst conviction about upside potential. Piper Sandler price target story
• Neutral Sentiment: Large institutional holders increased positions in the most recent quarter (Vanguard, State Street, Dodge & Cox), indicating steady long-term ownership but not an immediate catalyst. MarketBeat Cigna page
• Neutral Sentiment: Cigna executives presented at the TD Cowen healthcare conference this week — useful for incremental investor Q&A but not likely to move the stock materially. TD Cowen presentation notice
• Negative Sentiment: The market reacted negatively to the CEO succession announcement — investor concern about leadership transition appears to be a main driver of the decline despite the internal promotion. Seeking Alpha on leadership transition
• Negative Sentiment: Insider selling: Everett Neville and Nicole S. Jones reported sales (combined several thousand shares at roughly $288.91), which can amplify short-term pressure by signaling executive liquidity-taking. InsiderTrades alert Nicole S. Jones filing

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

Cigna Group Stock Performance

CI stock opened at $283.58 on Wednesday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The business has a 50-day moving average price of $280.48 and a 200 day moving average price of $284.45. The company has a market capitalization of $74.73 billion, a P/E ratio of 12.79, a PEG ratio of 1.01 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same period in the prior year, the business earned $6.64 EPS. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities research analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio is 27.23%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.